Literature DB >> 11316510

Regulations of opioid dependence by opioid receptor types.

M Narita1, M Funada, T Suzuki.   

Abstract

Three major types of opioid receptors, designated mu, delta, and kappa, are widely expressed in the CNS. Development of selective receptor ligands and recent cloning of each receptor have contributed greatly to our increasing knowledge of the neuropharmacological profile of each opioid receptor type. It is of interest to note that they include noncompetitive and allosteric interactions among their types. This review focuses on the functional interaction among these opioid receptor types that contribute to opioid dependence. Various studies provide arguments to support substantial roles for mu-opioid receptors and the possible involvement of delta-opioid receptors in the development of physical and psychological dependence on morphine. Noradrenergic transmission originating in the locus coeruleus is most likely to play the primary causal role in the expression of physical dependence on morphine. In contrast, many studies have pointed to the mesolimbic dopaminergic pathway projecting from the ventral tegmental area to the nucleus accumbens as a critical site for the initiation of psychological dependence on opioids. It is noteworthy as the broad existence of opposing interactions between mu/delta- and kappa-receptors in the brain. The activation of kappa-receptors leads to the suppression of unpleasant mu/delta-mediated side effects such as the rewarding effect. Considering the functional interaction among opioid receptor types, the co-administration of morphine-like compounds with kappa-receptor agonists may constitute a preferable and superior approach to the treatment of pain with fewer side effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316510     DOI: 10.1016/s0163-7258(00)00099-1

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  25 in total

1.  Chronic, but not acute morphine treatment, up-regulates alpha-Ca2+/calmodulin dependent protein kinase II gene expression in rat brain.

Authors:  Yuejun Chen; Yan Jiang; Wen Yue; Yuqing Zhou; Lin Lu; Lan Ma
Journal:  Neurochem Res       Date:  2008-04-12       Impact factor: 3.996

2.  Disruption of morphine-conditioned place preference by a delta2-opioid receptor antagonist: study of mu-opioid and delta-opioid receptor expression at the synapse.

Authors:  Sophie K Billa; Yan Xia; Jose A Morón
Journal:  Eur J Neurosci       Date:  2010-07-09       Impact factor: 3.386

3.  Reversal effect of intra-central amygdala microinjection of L-arginine on place aversion induced by naloxone in morphine conditioned rats.

Authors:  Sara Karimi; Manizheh Karami; Hedayat Sahraei; Mahnaz Rahimpour
Journal:  Iran Biomed J       Date:  2011

Review 4.  [The endogenous opioid system and drug addiction].

Authors:  R Maldonado
Journal:  Ann Pharm Fr       Date:  2010-01-21

5.  Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area.

Authors:  Colleen A McClung; Eric J Nestler; Venetia Zachariou
Journal:  J Neurosci       Date:  2005-06-22       Impact factor: 6.167

6.  Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation.

Authors:  José A Morón; Srinivas Gullapalli; Chirisse Taylor; Achla Gupta; Ivone Gomes; Lakshmi A Devi
Journal:  Neuropsychopharmacology       Date:  2009-12-02       Impact factor: 7.853

7.  Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion.

Authors:  Minoru Narita; Keisuke Mizuo; Hirokazu Mizoguchi; Mamoru Sakata; Michiko Narita; Leon F Tseng; Tsutomu Suzuki
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

8.  Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imaging.

Authors:  Jatinder S Josan; David L Morse; Liping Xu; Maria Trissal; Brenda Baggett; Peg Davis; Josef Vagner; Robert J Gillies; Victor J Hruby
Journal:  Org Lett       Date:  2009-06-18       Impact factor: 6.005

9.  Inhibition of the morphine-induced rewarding effect by direct activation of spinal protein kinase C in mice.

Authors:  Kousei Oe; Minoru Narita; Satoshi Imai; Masahiro Shibasaki; Chiharu Kubota; Akiko Kasukawa; Mami Hamaguchi; Yoshinori Yajima; Mitsuaki Yamazaki; Tsutomu Suzuki
Journal:  Psychopharmacology (Berl)       Date:  2004-06-04       Impact factor: 4.530

10.  Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth).

Authors:  Edward W Boyer; Kavita M Babu; Jessica E Adkins; Christopher R McCurdy; John H Halpern
Journal:  Addiction       Date:  2008-06       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.